Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details)

v3.22.2.2
Stockholders' Equity (Details) - USD ($)
3 Months Ended 9 Months Ended
Jul. 17, 2022
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Stockholders' Equity (Details) [Line Items]          
Restricted shares (in Shares)       12,000  
Vest contract term       24 months  
Stock-based compensation expense related to amortization   $ 6,075   $ 20,250  
Stock based compensation expense   672,083   2,273,947  
General and administrative expenses   584,237 $ 434,979 1,959,919 $ 1,871,473
Research and development expenses   87,846   314,028  
Unrecognized stock based compensation expense   $ 4,827,266   $ 4,827,266  
Weighted average remaining vesting period       2 years 3 months 18 days  
Aggregate shares (in Shares) 3,500,000        
Outstanding common stock percentage       9.99%  
Warrant shares (in Shares)       1,547,076  
Warrants exercised       $ 155  
Warrants unexercised (in Shares)       1,085,000  
Restricted Stock Units (RSUs) [Member]          
Stockholders' Equity (Details) [Line Items]          
Restricted shares issued (in Shares)   0   12,000  
Aggregate issuance date fair value   $ 0   $ 48,600  
Unrecognized stock based compensation expense   $ 28,350   $ 28,350  
Weighted average remaining vesting period       1 year 3 months 18 days  
Common Stock Issued For Services [Member]          
Stockholders' Equity (Details) [Line Items]          
Aggregate shares (in Shares)   55,112   151,010  
Aggregate issuance date fair value   $ 60,622   $ 270,967  
July 2022 Pre-Funded Warrants [Member]          
Stockholders' Equity (Details) [Line Items]          
Aggregate shares (in Shares) 2,632,076        
Warrants purchase price (in Dollars per share)       $ 0.0001  
July 2022 Common Warrants [Member]          
Stockholders' Equity (Details) [Line Items]          
Aggregate shares (in Shares) 6,132,076        
Outstanding common stock percentage       4.99%  
Warrants exercise price (in Dollars per share)   $ 1.06   $ 1.06  
Common warrants exercisable term   5 years   5 years  
July 2022 Offering [Member]          
Stockholders' Equity (Details) [Line Items]          
Warrants purchase price (in Dollars per share) $ 1.06        
Aggregate gross proceeds       $ 6,499,737